New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles

Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

FDA's MedWatch Safety Alerts for Consumers: June 2015

Tue, 28 Jul 2015 08:00:00 -0400

FDA is warning consumers about the Daytrana patch, ventricular assist systems, and a vascular patch.

FDA Strengthens Warning of Heart Attack and Stroke Risk for Non-Steroidal Anti-Inflammatory Drugs

Thu, 09 Jul 2015 08:00:00 -0400

FDA is strengthening the existing prescription and Drug Facts labels warning that nonsteroidal anti-inflammatory drugs (NSAIDs) – a group of drugs used for the temporary relief of pain and fever – can increase the chance of a heart attack or stroke, either of which can lead to death.

FDA: Use Only Approved Prescription Ear Drops

Wed, 01 Jul 2015 08:00:00 -0400

FDA is taking action against 16 prescription drugs labeled to relieve ear pain and swelling because they are unapproved and haven't been evaluated by FDA for safety, effectiveness and quality. Parents and other consumers still will have many other options for treating ear pain.

FDA’s MedWatch Safety Alerts for Consumers: April 2015

Thu, 25 Jun 2015 13:06:00 -0400

FDA is warning consumers about problems with mammograms at Coastal Diagnostic Center, Calif., and illegal Ebola Virus Test Kits.

Kids and Tobacco Use: Some Surprising Findings

Tue, 23 Jun 2015 08:00:00 -0400

Results of the National Youth Tobacco Survey provide a snapshot of tobacco products used by today's youth and reveal some surprising new trends.

Food and Drug Administration--Press Releases

FDA approves non-surgical temporary balloon device to treat obesity

Tue, 28 Jul 2015 16:41:00 -0400

The U.S. Food and Drug Administration today approved a new balloon device to treat obesity without the need for invasive surgery. The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is intended to facilitate weight loss in obese adult patients. The device likely works by occupying space in the stomach, which may trigger feelings of fullness, or by other mechanisms that are not yet understood.

FDA approves new treatment for chronic hepatitis C genotype 3 infections

Fri, 24 Jul 2015 13:44:00 -0400

The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.

FDA approves Praluent to treat certain patients with high cholesterol

Fri, 24 Jul 2015 14:15:00 -0400

The U.S. Food and Drug Administration today approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors.

FDA approves new treatment for most common form of advanced skin cancer

Fri, 24 Jul 2015 11:49:00 -0400

The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.

FDA approves Technivie for treatment of chronic hepatitis C genotype 4

Fri, 24 Jul 2015 11:04:00 -0400

The U.S. Food and Drug Administration today approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and poor liver function (cirrhosis).

Recalls RSS

NVIDIA Recalls Tablet Computers Due to Fire Hazard

Fri, 31 Jul 2015 07:30:00 GMT

The lithium-ion battery in the tablets can overheat.

Stork Craft Recalls Crib Mattresses Due to Violation of Federal Mattress Flammability Standard

Thu, 30 Jul 2015 13:00:00 GMT

The crib mattresses fail to meet the mandatory federal flammability standard for mattresses.

Nipponflex Recalls Mattresses Due to Violation of Federal Mattress Flammability Standard

Thu, 30 Jul 2015 12:00:00 GMT

The mattresses fail to meet the mandatory federal flammability standard for mattresses.

ACCO Brands Recalls Quartet Magnetic and Dry Erase Boards Due to Laceration Hazard

Thu, 30 Jul 2015 10:00:00 GMT

Sharp metal edges on the back of the boards can become exposed while removing mounted boards posing a laceration hazard.

Whirlpool Recalls Jenn-Air Wall Ovens Due to Risk of Burns

Wed, 29 Jul 2015 10:00:00 GMT

The extendable roller rack can unexpectedly disengage when fully extended, posing a risk of burns to consumers.